Literature DB >> 9771799

Chronic inflammatory demyelinating polyneuropathy during treatment with interferon-alpha.

M E Marzo, M Tintoré, O Fabregues, X Montalbán, A Codina.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9771799      PMCID: PMC2170291          DOI: 10.1136/jnnp.65.4.604

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  12 in total

Review 1.  Management of chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Richard A C Hughes
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Long-term efficacy of interferon-alpha in chronic inflammatory demyelinating polyneuropathy.

Authors:  Giovanni Pavesi; Luigi Cattaneo; Adriana Marbini; Franco Gemignani; Domenico Mancia
Journal:  J Neurol       Date:  2002-06       Impact factor: 4.849

Review 3.  Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Mohamed Mahdi-Rogers; Ruth Brassington; Angela A Gunn; Pieter A van Doorn; Richard Ac Hughes
Journal:  Cochrane Database Syst Rev       Date:  2017-05-08

4.  Screening for Electrophysiological Abnormalities in Chronic Hepatitis C Infection: Peripheral Neuropathy and Optic Neuropathy.

Authors:  Aslı Köşkderelioğlu; Pınar Ortan; Alpay Ari; Muhteşem Gedizlioğlu
Journal:  Noro Psikiyatr Ars       Date:  2016-03-01       Impact factor: 1.339

5.  Pericarditis and chronic inflammatory demyelinating polyneuropathy during therapy with pegylated interferon alfa-2a for chronic hepatitis C.

Authors:  Kazuaki Nishio; Takeshi Konndo; Shunichi Okada; Machiko Enchi
Journal:  World J Hepatol       Date:  2010-09-27

Review 6.  Newer therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Krista Kuitwaard; Pieter A van Doorn
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

7.  Acute inflammatory demyelinating polyneuropathy associated with pegylated interferon alpha 2a therapy for chronic hepatitis C virus infection.

Authors:  Vijay Khiani; Thomas Kelly; Adeel Shibli; Donald Jensen; Smruti R Mohanty
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

Review 8.  Vasculitic complications of interferon-alpha treatment for chronic hepatitis C virus infection: case report and review of the literature.

Authors:  Wilke Beuthien; Hans-Ullrich Mellinghoff; Johannes von Kempis
Journal:  Clin Rheumatol       Date:  2005-06-30       Impact factor: 3.650

9.  Acute inflammatory demyelinating polyneuropathy after treatment with pegylated interferon alfa-2a in a patient with chronic hepatitis C virus infection: a case report.

Authors:  Mounia Lahbabi; Meryem Ghissassi; Faouzi Belahcen; Sidi Adil Ibrahimi; Nouredine Aqodad
Journal:  J Med Case Rep       Date:  2012-09-04

10.  Deregulated Fcγ receptor expression in patients with CIDP.

Authors:  Isaak Quast; Flavio Cueni; Falk Nimmerjahn; Björn Tackenberg; Jan D Lünemann
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.